Objective: To describe ail medical patents granted in the United States to
Australian-resident inventors between 1984 and 1999.
Data sources: All patent data originated from the US Patent and Trademark O
ffice. Data for 1984-1994 were compiled by CHI Research inc, and data for 1
995-1999 were obtained from the Community of Science website.
Main outcome measures: Number of medical patents granted in the US to Austr
alian-resident inventors; assignees (owners) of these medical patents; prop
ortion of these medical patents related to biotechnology.
Results: From 1984 to 1999, 7835 utility patents were granted in the US to
Australian-resident inventors. Of these, 1308 patents (17%) were identified
as medical patents; 489 (37%) of these were biotechnology patents. Medical
patents account for an increasing proportion of all US patents granted to
Australian inventors, increasing from 10% in 1984 to 25% in 1999. Biotechno
logy accounted for an increasing proportion of medical patents, rising from
10% to 55% between 1984 and 1999. More than half the medical patents are o
wned by commercial interests, and 33% by only 14 organisations, six of whic
h are universities and their affiliated institutions.
Conclusion:Only a few organisations account for most of the patenting of me
dical technology. The inventors and their organisations listed on medical p
atents could be canvassed when developing government policy and targeted fo
r support in commercialising their medical technology.